Overview

A Study To Evaluate The Effects Of PF-05175157 In Healthy Volunteers

Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate pharmacodynamics of single oral doses of PF-05175157 in a dose-dependent fashion in healthy volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer